Placental infection of hepatitis B virus among Thai pregnant women: Clinical risk factors and its association with fetal infection

Prenat Diagn. 2020 Feb;40(3):380-386. doi: 10.1002/pd.5628. Epub 2019 Dec 25.

Abstract

Objectives: To identify the risk factors of placental and fetal infections among HBsAg-positive women.

Methods: A prospective cohort study involving HBsAg-positive pregnant women was conducted. Maternal risk factors, including serum HBeAg status, anti-HBcIgM, and HBV-DNA levels, were determined. Placental infection was identified by PCR and confirmed by DNA sequencing. Fetal infection was defined as a positive umbilical cord blood HBV-DNA at birth.

Results: A total of 96 HBsAg-positive women were enrolled in the study. The prevalence of placental infection was high (44 of 96; 45.8%) among HBsAg-positive women. The major risk factors for placental infection were high maternal viral load and the presence of HBeAg. Fetal infection was detected in one quarter of HBsAg-positive women (25 of 95; 25.3%). The risk of fetal infection was strongly associated with placental infection (78.3%), high maternal viral load, and the presence of HBeAg. There was no significant difference in perinatal outcomes between the groups with and without placental infection. Data on rates of chronic HBV infection in infants after fetal infection were not available.

Conclusion: A significant association between maternal measures of viral replication and placental and fetal infection was demonstrated. These findings suggest that transplacental infection prior to birth may be a mechanism contributing to the higher rates of newborn prophylaxis failure in women with a high viral load.

MeSH terms

  • Adult
  • Cohort Studies
  • Female
  • Fetal Diseases / virology*
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / physiology
  • Hepatitis B, Chronic / complications*
  • Hepatitis B, Chronic / diet therapy
  • Hepatitis B, Chronic / transmission*
  • Humans
  • Infectious Disease Transmission, Vertical* / prevention & control
  • Placenta Diseases / diagnosis
  • Placenta Diseases / virology*
  • Pregnancy
  • Pregnancy Complications, Infectious / virology*
  • Pregnancy Outcome
  • Prospective Studies
  • Risk Factors
  • Tenofovir / therapeutic use
  • Thailand
  • Viral Load

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Tenofovir